VANDAPHARMA0708

Company

Vanda Pharmaceuticals Inc.

Filed

August 11, 2008

Accession Number

0000053417-08-000065

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →